{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:04:50Z","timestamp":1787025890934,"version":"build-2736575974"},"reference-count":31,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2023,7,18]],"date-time":"2023-07-18T00:00:00Z","timestamp":1689638400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Alzheimer\u2019s Disease"],"published-print":{"date-parts":[[2023,8,29]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Increasing evidence illustrates the value of plasma biomarkers of Alzheimer\u2019s disease (AD) to screen for and identify dementia with Lewy bodies (DLB). However, confirmatory studies are needed to demonstrate the feasibility of these markers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>\n                      To determine the feasibility of plasma tau phosphorylated at threonine 181 (p-tau181) and amyloid-\u03b2\n                      <jats:sub>42<\/jats:sub>\n                      (A\u03b2\n                      <jats:sub>42<\/jats:sub>\n                      ) as potential biomarkers to differentiate AD and DLB.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      We evaluated plasma samples from patients with DLB ( n\u200a=\u200a47) and AD ( n\u200a=\u200a55) and healthy controls (HCs, n\u200a=\u200a30), using ELISAs to measure p-tau181 and A\u03b2\n                      <jats:sub>42<\/jats:sub>\n                      . Additionally, we examined neuropsychological assessment scores for participants. The plasma biomarkers were investigated for correlation with neuropsychological assessments and discriminant ability to identify DLB.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Plasma p-tau181 was significantly lower in DLB than in AD and HCs. Plasma A\u03b2\n                      <jats:sub>42<\/jats:sub>\n                      was significantly higher in DLB than in AD but lower in DLB than in HCs. We found good correlations between plasma A\u03b2\n                      <jats:sub>42<\/jats:sub>\n                      and neuropsychological scores in the whole cohort, while p-tau181 was associated with cognitive status in DLB. In the distinction between DLB and HCs, plasma p-tau181 and A\u03b2\n                      <jats:sub>42<\/jats:sub>\n                      showed similar accuracy, while A\u03b2\n                      <jats:sub>42<\/jats:sub>\n                      showed better accuracy than p-tau181 in discriminating DLB and AD.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>\n                      In a single-center clinical cohort, we confirmed the high diagnostic value of plasma p-tau181 and A\u03b2\n                      <jats:sub>42<\/jats:sub>\n                      for distinguishing patients with DLB from HCs. Plasma A\u03b2\n                      <jats:sub>42<\/jats:sub>\n                      improved the differential diagnosis of DLB from AD.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3233\/jad-230085","type":"journal-article","created":{"date-parts":[[2023,7,18]],"date-time":"2023-07-18T12:17:31Z","timestamp":1689682651000},"page":"161-169","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":3,"title":["Plasma Phosphorylated Tau181 and Amyloid-\u03b242 in Dementia with Lewy Bodies Compared with Alzheimer\u2019s Disease and Cognitively Healthy People"],"prefix":"10.1177","volume":"95","author":[{"given":"Yueyi","family":"Yu","sequence":"first","affiliation":[{"name":"Innovation Center for Neurological Disorders, Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Xia","sequence":"additional","affiliation":[{"name":"Innovation Center for Neurological Disorders, Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China"},{"name":"National Center for Neurological Disorders, National Clinical Research Center for Geriatric Diseases, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaosheng","family":"Meng","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Li","sequence":"additional","affiliation":[{"name":"Innovation Center for Neurological Disorders, Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Qin","sequence":"additional","affiliation":[{"name":"Innovation Center for Neurological Disorders, Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China"},{"name":"National Center for Neurological Disorders, National Clinical Research Center for Geriatric Diseases, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2023,7,18]]},"reference":[{"key":"ref001","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-019-0306-8"},{"key":"ref002","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)00462-6"},{"key":"ref003","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291713000494"},{"key":"ref004","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000004058"},{"key":"ref005","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-020-0348-0"},{"key":"ref006","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(16)30291-5"},{"key":"ref007","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-0755-1"},{"key":"ref008","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01348-z"},{"key":"ref009","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2019.1632"},{"key":"ref010","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.34.7.939"},{"key":"ref011","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-210342"},{"key":"ref012","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2020.09.030"},{"key":"ref013","doi-asserted-by":"publisher","DOI":"10.1016\/j.jagp.2019.12.009"},{"key":"ref014","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2018.00123"},{"key":"ref015","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000010943"},{"key":"ref016","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-019-0537-5"},{"key":"ref017","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-020-00684-5"},{"key":"ref018","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-017-0276-4"},{"key":"ref019","doi-asserted-by":"publisher","DOI":"10.1038\/srep26801"},{"key":"ref020","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.57.1.100"},{"key":"ref021","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.114.143347"},{"key":"ref022","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-022-01093-6"},{"key":"ref023","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2022.07.008"},{"key":"ref024","doi-asserted-by":"publisher","DOI":"10.1002\/mds.28370"},{"key":"ref025","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2021.4222"},{"key":"ref026","doi-asserted-by":"publisher","DOI":"10.1002\/mds.28994"},{"key":"ref027","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-020-00923-z"},{"key":"ref028","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-022-00384-x"},{"key":"ref029","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2022.05.020"},{"key":"ref030","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2021-327788"},{"key":"ref031","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-210272"}],"container-title":["Journal of Alzheimer\u2019s Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.3233\/JAD-230085","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.3233\/JAD-230085","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.3233\/JAD-230085","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:08:18Z","timestamp":1777370898000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.3233\/JAD-230085"}},"subtitle":[],"editor":[{"given":"Jin-Tai","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2023,7,18]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,8,29]]}},"alternative-id":["10.3233\/JAD-230085"],"URL":"https:\/\/doi.org\/10.3233\/jad-230085","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,18]]}}}